Factors like nutrition and muscle strength and size are all involved when it comes to your running speed, and your genetics ...

In a previous animal study, scientists searched for the genetic culprits behind muscle weakening, but they used a single strain in order to limit unexplainable variation in the results. 3 “That’s like ...

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...

Givinostat (Duvyzat) is the first non-steroid drug approved to treat people with all genetic variations of DMD. It delays the disease's progression by targeting an enzyme involved in muscle growth ...

Dyne Therapeutics started the new year with proof-of-concept clinical data for experimental genetic medicines addressing two rare muscle diseases—one of which has no FDA-approved treatments.

EZH1 steadies gene-reading machinery and adjusts DNA packaging, ensuring genes activate on time to maintain 24-hour rhythms.

EZH1 is a key regulator of circadian rhythms, stabilizing gene transcription and modifying chromatin to maintain genetic ...

Research in the Leinwand lab focuses on unraveling mechanisms of genetic heart and skeletal muscle diseases using animal models, cell-culture systems and biophysical approaches. In addition to ...